IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences PR Newswire STOCKHOLM, Oct. 5, 2022 IRRAS will...
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study PR Newswire STOCKHOLM, Aug. 23, 2022...
IRRAS AB publishes Interim Report for the period January to June 2022 PR Newswire STOCKHOLM, July 22, 2022 STOCKHOLM, July 22, 2022 /PRNewswire/...
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus...
IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and Certifications PR Newswire STOCKHOLM, May 11, 2021...
IRRAS AB publishes Interim Report for the period January to March 2021 PR Newswire STOCKHOLM, May 4, 2021 -Â Meaningful Commercial Acceleration...
IRRAS AB publishes Interim Report for the period January to March 2021 Meaningful Commercial Acceleration Seen Globally PR Newswire STOCKHOLM...
IRRAS Promotes Will Martin to Chief Executive Officer Having established a strong manufacturing, clinical and regulatory foundation, Company to...
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow PR...
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow - The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.